Why Freshpet Was a Dog of a Stock This Week
On the back of a recommendation downgrade from one analyst and price target cuts from two others, investors sold out of the ...
Is Colgate-Palmolive Quietly Building The Next Pet Food Empire?
Colgate-Palmolive’s premium strategy and pet nutrition expansion drive growth, with a $115 target signaling 26% upside. Read more about CL stock here.
BNY Mellon Small Cap Growth Fund Q4 2024 Commentary
BNY Mellon Small Cap Growth Fund outperformed its benchmark, the Russell 2000 Growth Index during Q4 2024. Click here to read ...
Bristol Myers announces EC approval of Breyanzi
Squibb announced that the European Commission has granted approval to Breyanzi, a CD19-directed chimeric antigen receptor T ...
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on 2seventy Bio (TSVT) to $5 from $6 and keeps an Equal Weight rating on the shares following ...